Car-T News
- Our Team Attended CART25: Advancing CAR-T Therapy in Europe
- Fighting NK/T Cell Lymphoma with CAR-T Cell Therapy
- Promising New T-Cell Therapy Reduces Tumor Size in Initial Trials
- FDA Greenlights TALVEY, a New Drug for Tough-to-Treat Multiple Myeloma
- Innovations in Using CD7-Targeted CAR T-Cells for Hard-to-Treat Blood Cancers
- Promising Results for High-Risk Multiple Myeloma with Ide-Cel CAR T Therapy
- Does CAR T-cell therapy leave patients vulnerable to infection?
- CAR T for Large B Cell Lymphoma: Researchers Identify Key Characteristics Associated with Improved Outcomes
- Comprehensive Study Reveals Promising New Targets for CAR T-Cell Cancer Therapy
- TIL Melanoma therapy is approved by FDA in the USA
- New CAR T-Cell Therapy Offers Hope for LBCL Patients After Previous CAR-T Treatment
- Predicting CAR-T Therapy Success in Multiple Myeloma with a Simple Blood Test
- Introducing CAR-E to Combat Cancer Relapse and Improve Treatment Efficacy
- Boosting CAR-T Cell Therapy: NT-I7 Shows Promising Results
- Advanced Strategies in CAR T-Cell Therapy for Solid Tumors
- Breakthrough in CAR-T Cell Reactivation for Multiple Myeloma
- CAR-T therapy in Brazil
